See What HealthDay Can Do For You
Contact Us

Clinical Trials Update: Oct. 22, 2003

Bladder Cancer Diabetes - Type 2 Bipolar Disorders

(HealthDayNews) -- Here are the latest clinical trials, courtesy of CenterWatch:

Bladder Cancer

A research study to test the effectiveness and safety of an investigational medication for bladder cancer. Volunteers who have transitional cell bladder cancer, stage Ta, T1 and/ or CIS may be eligible. Research site located in Nyack, New York.

More Information

Please see http://www.centerwatch.com/patient/studies/cat26.html.

-----

Diabetes - Type 2

A research study of an investigational medication for type 2 diabetes. Volunteers age 18-70 who are taking metformin only for their diabetes, and whose blood sugar is not well controlled, may be eligible. Research site located in Lafayette, Indiana.

More Information

Please see http://www.centerwatch.com/patient/studies/cat603.html.

-----

Bipolar Disorders

A study to determine the safety and effectiveness of an investigational medication in the treatment of bipolar disorder, manic or mixed type in adults. Volunteers age 18-65 who have a current primary diagnosis of bipolar I disorder, manic or mixed type may be eligible. Research site located in Jackson, Mississippi.

More Information

Please see http://www.centerwatch.com/patient/studies/cat20.html.

-----

Copyright 2003 CenterWatch. All rights reserved.

Consumer News

HealthDay

HealthDay is the world’s largest syndicator of health news and content, and providers of custom health/medical content.

Consumer Health News

A health news feed, reviewing the latest and most topical health stories.

Professional News

A news feed for Health Care Professionals (HCPs), reviewing latest medical research and approvals.